Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Spinal Cord Neoplasms 1Sleep Deprivation 1Intracranial Aneurysm 1Breast Cancer Patients 1Breast Cancer Female 1Brain Neoplasms 1Abdominal Cancer 1

Interventions

Oxaliplatin 56Capecitabine 49Fluorouracil 37Cisplatin 37S 1 (combination) 23Paclitaxel 18Docetaxel 18Leucovorin 16pembrolizumab 13Irinotecan 12apatinib 11titanium silicide 9XELOX 9Trastuzumab 9Nivolumab 9Hyperthermic Intraperitoneal Chemotherapy 8Epirubicin 8Drug Therapy 8Tegafur 7Radiotherapy 6Neoadjuvant Therapy 6gimeracil 5Surgical Procedures, Operative 5Gastrectomy 5Chemotherapy, Adjuvant 5tislelizumab 4S-1 plus cisplatin 4Ramucirumab 4zolbetuximab 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Stomach Neoplasms × Dexmedetomidine × Clear all
NCT03117023 2017-04-17

The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer

Nanjing PLA General Hospital

Phase 3 Unknown
50 enrolled
Gastrointestinal

Sleep Deprivation, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡